These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 20397038

  • 1. Normalization of generalized retinal function and progression of maculopathy after cessation of therapy in a case of severe hydroxychloroquine retinopathy with 19 years follow-up.
    Salu P, Uvijls A, van den Brande P, Leroy BP.
    Doc Ophthalmol; 2010 Jun; 120(3):251-64. PubMed ID: 20397038
    [Abstract] [Full Text] [Related]

  • 2. Case Report: Hydroxychloroquine Retinopathy.
    Eldeeb M, Chan EW, Omar A.
    Optom Vis Sci; 2018 Jun; 95(6):545-549. PubMed ID: 29787487
    [Abstract] [Full Text] [Related]

  • 3. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M, Stover NB, Francis PJ, Weleber RG.
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [Abstract] [Full Text] [Related]

  • 4. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.
    Mavrikakis I, Sfikakis PP, Mavrikakis E, Rougas K, Nikolaou A, Kostopoulos C, Mavrikakis M.
    Ophthalmology; 2003 Jul; 110(7):1321-6. PubMed ID: 12867385
    [Abstract] [Full Text] [Related]

  • 5. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.
    Chang WH, Katz BJ, Warner JE, Vitale AT, Creel D, Digre KB.
    Retina; 2008 Jul; 28(10):1478-86. PubMed ID: 18997610
    [Abstract] [Full Text] [Related]

  • 6. Perifoveal interdigitation zone loss in hydroxychloroquine toxicity leads to subclinical bull's eye lesion appearance on near-infrared reflectance imaging.
    Chew AL, Sampson DM, Chelva E, Khan JC, Chen FK.
    Doc Ophthalmol; 2018 Feb; 136(1):57-68. PubMed ID: 29124422
    [Abstract] [Full Text] [Related]

  • 7. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
    Maturi RK, Yu M, Weleber RG.
    Arch Ophthalmol; 2004 Jul; 122(7):973-81. PubMed ID: 15249360
    [Abstract] [Full Text] [Related]

  • 8. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy.
    Melles RB, Marmor MF.
    JAMA Ophthalmol; 2014 Dec; 132(12):1453-60. PubMed ID: 25275721
    [Abstract] [Full Text] [Related]

  • 9. Visual field and multifocal electroretinography and their correlations in patients on hydroxychloroquine therapy.
    Lai TY, Ngai JW, Chan WM, Lam DS.
    Doc Ophthalmol; 2006 May; 112(3):177-87. PubMed ID: 16804707
    [Abstract] [Full Text] [Related]

  • 10. Hydroxychloroquine retinopathy.
    Weiner A, Sandberg MA, Gaudio AR, Kini MM, Berson EL.
    Am J Ophthalmol; 1991 Nov 15; 112(5):528-34. PubMed ID: 1951589
    [Abstract] [Full Text] [Related]

  • 11. Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine.
    Tanga L, Centofanti M, Oddone F, Parravano M, Parisi V, Ziccardi L, Kroegler B, Perricone R, Manni G.
    Graefes Arch Clin Exp Ophthalmol; 2011 May 15; 249(5):715-21. PubMed ID: 21253758
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography.
    So SC, Hedges TR, Schuman JS, Quireza ML.
    Ophthalmic Surg Lasers Imaging; 2003 May 15; 34(3):251-8. PubMed ID: 12757106
    [Abstract] [Full Text] [Related]

  • 13. Night Blindness, Ring Scotoma, and a Nonrecordable Electroretinogram in an Elderly Woman.
    Grassi MA, Maker MP, Marmor MF.
    JAMA Ophthalmol; 2019 Jan 01; 137(1):109-110. PubMed ID: 30452517
    [No Abstract] [Full Text] [Related]

  • 14. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
    Mititelu M, Wong BJ, Brenner M, Bryar PJ, Jampol LM, Fawzi AA.
    JAMA Ophthalmol; 2013 Sep 01; 131(9):1187-97. PubMed ID: 23887202
    [Abstract] [Full Text] [Related]

  • 15. Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host disease.
    Navajas EV, Krema H, Hammoudi DS, Lipton JH, Simpson ER, Boyd S, Easterbrook M.
    Can J Ophthalmol; 2015 Dec 01; 50(6):442-50. PubMed ID: 26651304
    [Abstract] [Full Text] [Related]

  • 16. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
    Allahdina AM, Chen KG, Alvarez JA, Wong WT, Chew EY, Cukras CA.
    Retina; 2019 Mar 01; 39(3):473-484. PubMed ID: 30741731
    [Abstract] [Full Text] [Related]

  • 17. Hydroxychloroquine retinopathy.
    Maturi RK, Folk JC, Nichols B, Oetting TT, Kardon RH.
    Arch Ophthalmol; 1999 Sep 01; 117(9):1262-3. PubMed ID: 10496407
    [No Abstract] [Full Text] [Related]

  • 18. Retinal toxicity secondary to Plaquenil therapy.
    Hanna B, Holdeman NR, Tang RA, Schiffman JS.
    Optometry; 2008 Feb 01; 79(2):90-4. PubMed ID: 18215798
    [Abstract] [Full Text] [Related]

  • 19. Macular toxicity after short-term hydroxychloroquine therapy.
    Pasaoglu I, Onmez FE.
    Indian J Ophthalmol; 2019 Feb 01; 67(2):289-292. PubMed ID: 30672499
    [Abstract] [Full Text] [Related]

  • 20. New trends in early diagnosis of hydroxychloroquine toxic retinopathy.
    Vanderzee G, Tassi D.
    Optometry; 2012 May 31; 83(5):200-7. PubMed ID: 23249122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.